After graduating with a degree in Biophysics from the University Of California, Dr. Zolnoun attended the University of Illinois School of Medicine. She completed her residency at Rochester General Hospital in Rochester, NY. In 1999, Dr. Zolnoun became a fellow in the department of obstetrics and gynecology in advanced laparoscopy and gynecological pain at the UNC-Chapel Hill, where she is currently practicing. Since 2006, Dr. Zolnoun has been the director of the vulvar pain clinic and the pelvic pain research unit for the department of obstetrics and gynecology at UNC. She is also an associate professor for UNC School of Medicine and has been nominated in the past by students for Faculty Mentoring Awards.
Dr. Zolnoun has published 21 journal articles on the topics of vulvodynia, dyspareunia, and vulvar vestibulitis. She has also given numerous lectures and presentations on gynecological pain and has dedicated her research on discovering the causes and possible treatments of these disabling disorders.
Dr. Zolnoun has investigated the treatment of chronic pelvic with Thalidomide and 5% Lidocaine. By researching these two medications, Dr. Zolnoun has debunked any negative misconceptions that the public as well as medical professionals have about using them. Dr. Zolnoun has been head of the game when it comes to gynecological research and to the technology used in those experiments. To evaluate skin and muscle sensitivities Dr. Zolnoun has engineered her own techniques with devices that she has used to define and treat women with vulvar vestibulitis. The Wagner algometer is a device used in Dr. Zolnoun’s clinical research to evaluate the pain perception in the vaginal wall. Thimble used to assess muscles of the pelvic floor. This device has been successful in evaluating women with chronic pelvic pain